Solgate GmbH
Klosterneuburg, AT · 1 known investors
Solgate develops a cell-based technology platform for discovering drugs that target solute carrier transporters, which regulate nutrient transport across cell membranes. The company focuses on accelerating the creation of medicines for patients with severe metabolic diseases.
AI & Machine LearningBiotechDeep Tech